Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Feb
1
2023
EPO and IEA Release Hydrogen Patent Report Showing Automotive Sector Plays a Key Role in Innovation Foley & Lardner LLP
Mar
27
2023
IP Lawyer vs. ChatGPT: Top 10 Legal Issues of Using Generative AI at Work Foley & Lardner LLP
Aug
16
2018
Restoring America’s Leadership in Innovation Act of 2018 Foley & Lardner LLP
Oct
11
2018
Federal Circuit Finds Detection Claims Invalid Under 101 Foley & Lardner LLP
Nov
13
2018
Not-Quite Prior Art Supports Obviousness Of Copaxone Patents In IPR Proceedings Foley & Lardner LLP
Dec
15
2015
Biosimilar Pre-Marketing Notice Always Required Foley & Lardner LLP
Jun
27
2023
Protecting Innovations in SaMD & Biomedical Applications Foley & Lardner LLP
Aug
7
2023
Trends In Orange Book and Biologic PTAB Trials Foley & Lardner LLP
Feb
4
2016
High Stakes Race Between Apple and VirnetX: Will PTAB Trump Texas Jury's Award of $326.5M? Foley & Lardner LLP
Feb
16
2016
Athletic Shoe Lawsuits are Off and Running Foley & Lardner LLP
Oct
20
2023
Prosecution Laches—Another Arrow In The Quiver For Challenging Patents Foley & Lardner LLP
Jun
28
2019
Buyer Beware: Post-Facto Mergers a New Potential IPR Killer Foley & Lardner LLP
Dec
20
2023
The Barbie Movie: The Power of Brand Placement and Partnerships Foley & Lardner LLP
Sep
5
2019
Automotive MarketTrends | September 2019, Issue 3 Foley & Lardner LLP
Apr
27
2016
Reading Cuozzo Tea Leaves: Best Practices for IPR Proceedings Pending Supreme Court's Decision Foley & Lardner LLP
May
17
2016
DOJ Files Inter Partes Review Petitions Against Discovery Patents Foley & Lardner LLP
Jun
13
2016
PTAB Holds Technical Difficulties Will Not Save Late-Filed IPR Petitions Foley & Lardner LLP
Mar
10
2020
Consisting Essentially Of Trouble Foley & Lardner LLP
Jul
27
2016
Magnum Offers New Path for Challenging AIA Decisions: Burden of Production Foley & Lardner LLP
Sep
3
2020
CBM Review: A Postmortem Foley & Lardner LLP
Nov
10
2020
Federal Circuit Limits Venue In ANDA Litigation Foley & Lardner LLP
Feb
14
2017
Federal Circuit Again Reverses PTAB Obviousness Determination Foley & Lardner LLP
Feb
10
2021
In Arthrex Reply Brief, Government Reiterates and Stands Firm Foley & Lardner LLP
Jul
17
2017
Impact of TC Heartland on ANDA and Biosimilar Litigation Foley & Lardner LLP
Mar
1
2015
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute Foley & Lardner LLP
Apr
7
2015
Waiting On Sequenom: Pharma Patents Foley & Lardner LLP
Oct
3
2017
Federal Circuit Schools USPTO On Broadest Reasonable Claim Construction Foley & Lardner LLP
May
31
2022
USPTO Open for Some In-Person Business Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins